Key Details
Price
$0.03Annual ROE
-85.17%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 02, 2023Recent annual earnings:
Feb 27, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
11 May '23 Morgan Stanley
Equal-Weight11 May '23 B. Riley Securities
Neutral24 Apr '23 Piper Sandler
Overweight17 Apr '23 Jefferies
Hold14 Apr '23 Stifel
Hold14 Apr '23 Oppenheimer
Perform14 Apr '23 Morgan Stanley
Equal-Weight14 Apr '23 BTIG
Neutral28 Feb '23 Oppenheimer
Outperform18 Nov '22 Morgan Stanley
Equal-WeightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
ViewRay doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Why Is ViewRay (VRAY) Stock Down 69% Today?
VRAY
InvestorPlace17 July 2023
ViewRay (NASDAQ: VRAY ) stock is falling hard on Monday after the MRI company announced its voluntary Chapter 11 bankruptcy filing! According to the company's bankruptcy filing, ViewRay intends to pursue the sale of its business as part of the Chapter 11 process.
ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn
VRAY
Seeking Alpha13 April 2023
Magnetic resonance imaging-guided radiation therapy system provider ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. Expected 2023 revenue growth range slashed from a range of 25% to 40% to a new range of 0% to 15%.
FAQ
- What is the primary business of ViewRay?
- What is the ticker symbol for ViewRay?
- Does ViewRay pay dividends?
- What sector is ViewRay in?
- What industry is ViewRay in?
- What country is ViewRay based in?
- When did ViewRay go public?
- Is ViewRay in the S&P 500?
- Is ViewRay in the NASDAQ 100?
- Is ViewRay in the Dow Jones?
- When was ViewRay's last earnings report?
- When does ViewRay report earnings?
- Should I buy ViewRay stock now?
What is the primary business of ViewRay?
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What is the ticker symbol for ViewRay?
The ticker symbol for ViewRay is NASDAQ:VRAY
Does ViewRay pay dividends?
No, ViewRay does not pay dividends
What sector is ViewRay in?
ViewRay is in the Healthcare sector
What industry is ViewRay in?
ViewRay is in the Medical Devices industry
What country is ViewRay based in?
ViewRay is headquartered in United States
When did ViewRay go public?
ViewRay's initial public offering (IPO) was on 10 August 2015
Is ViewRay in the S&P 500?
No, ViewRay is not included in the S&P 500 index
Is ViewRay in the NASDAQ 100?
No, ViewRay is not included in the NASDAQ 100 index
Is ViewRay in the Dow Jones?
No, ViewRay is not included in the Dow Jones index
When was ViewRay's last earnings report?
ViewRay's most recent earnings report was on 2 August 2023
When does ViewRay report earnings?
The date for ViewRay's next earnings report has not been announced yet
Should I buy ViewRay stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions